Cargando…
Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c)
The modeling approach described here is designed to support the development of spreadsheet-based simple predictive models. It is based on 3 pillars: association of the complications with HbA1c changes, incidence of the complications, and average cost per event of the complication. For each pillar, t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478016/ https://www.ncbi.nlm.nih.gov/pubmed/27510441 http://dx.doi.org/10.1177/1932296816662048 |
_version_ | 1783244881793122304 |
---|---|
author | Fortwaengler, Kurt Parkin, Christopher G. Neeser, Kurt Neumann, Monika Mast, Oliver |
author_facet | Fortwaengler, Kurt Parkin, Christopher G. Neeser, Kurt Neumann, Monika Mast, Oliver |
author_sort | Fortwaengler, Kurt |
collection | PubMed |
description | The modeling approach described here is designed to support the development of spreadsheet-based simple predictive models. It is based on 3 pillars: association of the complications with HbA1c changes, incidence of the complications, and average cost per event of the complication. For each pillar, the goal of the analysis was (1) to find results for a large diversity of populations with a focus on countries/regions, diabetes type, age, diabetes duration, baseline HbA1c value, and gender; (2) to assess the range of incidences and associations previously reported. Unlike simple predictive models, which mostly are based on only 1 source of information for each of the pillars, we conducted a comprehensive, systematic literature review. Each source found was thoroughly reviewed and only sources meeting quality expectations were considered. The approach allows avoidance of unintended use of extreme data. The user can utilize (1) one of the found sources, (2) the found range as validation for the found figures, or (3) the average of all found publications for an expedited estimate. The modeling approach is intended for use in average insulin-treated diabetes populations in which the baseline HbA1c values are within an average range (6.5% to 11.5%); it is not intended for use in individuals or unique diabetes populations (eg, gestational diabetes). Because the modeling approach only considers diabetes-related complications that are positively associated with HbA1c decreases, the costs of negatively associated complications (eg, severe hypoglycemic events) must be calculated separately. |
format | Online Article Text |
id | pubmed-5478016 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-54780162018-03-01 Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c) Fortwaengler, Kurt Parkin, Christopher G. Neeser, Kurt Neumann, Monika Mast, Oliver J Diabetes Sci Technol Review Articles The modeling approach described here is designed to support the development of spreadsheet-based simple predictive models. It is based on 3 pillars: association of the complications with HbA1c changes, incidence of the complications, and average cost per event of the complication. For each pillar, the goal of the analysis was (1) to find results for a large diversity of populations with a focus on countries/regions, diabetes type, age, diabetes duration, baseline HbA1c value, and gender; (2) to assess the range of incidences and associations previously reported. Unlike simple predictive models, which mostly are based on only 1 source of information for each of the pillars, we conducted a comprehensive, systematic literature review. Each source found was thoroughly reviewed and only sources meeting quality expectations were considered. The approach allows avoidance of unintended use of extreme data. The user can utilize (1) one of the found sources, (2) the found range as validation for the found figures, or (3) the average of all found publications for an expedited estimate. The modeling approach is intended for use in average insulin-treated diabetes populations in which the baseline HbA1c values are within an average range (6.5% to 11.5%); it is not intended for use in individuals or unique diabetes populations (eg, gestational diabetes). Because the modeling approach only considers diabetes-related complications that are positively associated with HbA1c decreases, the costs of negatively associated complications (eg, severe hypoglycemic events) must be calculated separately. SAGE Publications 2017-03-01 /pmc/articles/PMC5478016/ /pubmed/27510441 http://dx.doi.org/10.1177/1932296816662048 Text en © 2016 Diabetes Technology Society http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution 3.0 License (http://www.creativecommons.org/licenses/by/3.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Articles Fortwaengler, Kurt Parkin, Christopher G. Neeser, Kurt Neumann, Monika Mast, Oliver Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c) |
title | Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c) |
title_full | Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c) |
title_fullStr | Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c) |
title_full_unstemmed | Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c) |
title_short | Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c) |
title_sort | description of a new predictive modeling approach that correlates the risk and associated cost of well-defined diabetes-related complications with changes in glycated hemoglobin (hba1c) |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478016/ https://www.ncbi.nlm.nih.gov/pubmed/27510441 http://dx.doi.org/10.1177/1932296816662048 |
work_keys_str_mv | AT fortwaenglerkurt descriptionofanewpredictivemodelingapproachthatcorrelatestheriskandassociatedcostofwelldefineddiabetesrelatedcomplicationswithchangesinglycatedhemoglobinhba1c AT parkinchristopherg descriptionofanewpredictivemodelingapproachthatcorrelatestheriskandassociatedcostofwelldefineddiabetesrelatedcomplicationswithchangesinglycatedhemoglobinhba1c AT neeserkurt descriptionofanewpredictivemodelingapproachthatcorrelatestheriskandassociatedcostofwelldefineddiabetesrelatedcomplicationswithchangesinglycatedhemoglobinhba1c AT neumannmonika descriptionofanewpredictivemodelingapproachthatcorrelatestheriskandassociatedcostofwelldefineddiabetesrelatedcomplicationswithchangesinglycatedhemoglobinhba1c AT mastoliver descriptionofanewpredictivemodelingapproachthatcorrelatestheriskandassociatedcostofwelldefineddiabetesrelatedcomplicationswithchangesinglycatedhemoglobinhba1c |